Riskpilot← Back to searchSign inGet full accessAPOTEKFORENINGEN
FLIActiveOrg 971033541Slemdalsveien 1, 0369 OsloActivities of business and employers membership organisations · NACE 9411Est. 188114 employeesapotek.no
Revenue 2024
NOK 24,3M
+5% vs 2023
EBITDA margin
-314.8%
+1% vs 2023
Equity ratio
97.6%
Financial strength
Net profit 2024
NOK 144,1M
+106% vs 2023
| Revenue | NOK 24,3M | +5% |
| EBITDA | NOK -76,4M | +1% |
| Net profit | NOK 144,1M | +106% |
| Total assets | NOK 1,4B | +12% |
| Equity | NOK 1,4B | +12% |
| Employees | 14 | — |
Legal name
APOTEKFORENINGEN
Org number
971033541
Legal form
Forening/Lag/Innretning
NACE code
9411 · Activities of business and employers membership organisations
Founded
16. mai 1881
Share capital
—
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Slemdalsveien 1, 0369 Oslo
Website
apotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 17 349 | 17 777 | 19 557 | 21 060 | 22 205 | 23 133 | 24 282 |
| Staff expenses | −21 095 | −22 557 | −22 828 | −25 733 | −25 468 | −26 243 | −27 737 |
| EBITDA | −17 342 | −21 497 | −147 721 | −41 186 | −72 639 | −77 347 | −76 434 |
| Depreciation & amort. | −13 | −52 | −0 | −0 | −9 | −18 | −18 |
| EBIT | −17 355 | −21 549 | −147 721 | −41 186 | −72 647 | −77 365 | −76 452 |
| Net financials | 34 253 | 41 741 | 47 219 | 1 079 473 | 9 383 | 147 187 | 220 586 |
| Profit before tax | 16 898 | 20 192 | −100 502 | 1 038 287 | −63 264 | 69 822 | 144 134 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 16 898 | 20 192 | −100 502 | 1 038 287 | −63 264 | 69 822 | 144 134 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 274 851 | 294 753 | 304 741 | 1 250 135 | 1 160 880 | 1 240 530 | 1 387 864 |
| Equity | 245 682 | 265 874 | 165 372 | 1 203 660 | 1 140 396 | 1 210 218 | 1 354 352 |
| Long-term debt | 5 129 | 1 975 | 114 973 | −12 157 | −13 406 | −19 864 | 0 |
| Short-term debt | 4 297 | 6 853 | 4 342 | 34 318 | 7 078 | 10 448 | 10 610 |
| Total debt | 19 297 | 18 853 | 129 342 | 34 318 | 7 078 | 10 448 | 10 610 |
EBITDA margin
-314.8%
This company
15.8%
Market median
-2092% vs market
20182024
Equity ratio
97.6%
This company
38.2%
Market median
+155% vs market
20182024
Return on equity
10.6%
This company
18.4%
Market median
+42% vs market
20182024
Net profit margin
593.6%
This company
8.1%
Market median
+7228% vs market
20182024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20182024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PT Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2025 | — | — | |
| Deputy Chairman | 2020 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
APOTEKFORENINGEN 
FARMALOGG ASBoard members of APOTEKFORENINGEN also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Torgeir Lund | Chief Executive Officer | 0 companies |
| Jaan Ivar Gjærum Semlitsch | Board of Directors | 0 companies |
| Anders Per Erik Larsson | Board of Directors | 0 companies |
| Ros-Marie Soo Yeun Grusén | Board of Directors | 0 companies |
| Terje Kvaal | Board of Directors | 0 companies |
| Øyvind Andreas Winther | Deputy Chairman | 0 companies |
| Rune Spikseth | Board of Directors | 0 companies |
| Tore Prestegard | Board of Directors | 0 companies |
| Håvard Røkke | Board of Directors | 0 companies |
| Kristin Veierød | Chairman | 0 companies |
| Kathrine Mehlin Wessel | Board of Directors | 0 companies |
| Lars Haukaas | Chairman | 0 companies |